Abciximab versus aspirin for prevention of stroke recurrence before endarterectomy in symptomatic >50% carotid stenosis: a pilot study (ASTERICS)

Trial Profile

Abciximab versus aspirin for prevention of stroke recurrence before endarterectomy in symptomatic >50% carotid stenosis: a pilot study (ASTERICS)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 May 2007

At a glance

  • Drugs Abciximab; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms ASTERICS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 May 2007 Status changed from suspended to discontinued.
    • 11 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top